Hints and tips:
...The medical device and healthcare company Abbott Laboratories, based on Chicago’s farther outskirts, has leased offices in the city’s most famous downtown skyscraper, the Willis Tower....
...institutions and professional investors are increasingly seeking greater control by adding more customised emerging market exposures to their portfolios,” said Matthews Asia chief executive officer Cooper Abbott...
...“I think this is a moment when, by and large, allocations towards emerging markets, towards Asia and towards China are pretty low, maybe at all-time lows,” Cooper Abbott, chief executive of Matthews Asia...
...The commitments from those new investors were “a massive vote of confidence” in the company, the future of business travel and the opportunities in the sector, Paul Abbott, GBT chief executive, told the...
...POA, kaiahealth.com Air quality AirPop Halo Sensor Developed pre-pandemic after co-founder Chris Hosmer discovered that his two-year-old and newborn were both suffering from acute respiratory illnesses...
...But Mr Rosa is not fully satisfied: “What Covid-19 has taught us is that diagnostics must focus on respiratory diseases....
...report on how Chinese social media platforms, including Tencent’s WeChat, censored keywords related to coronavirus as early as December. 2 . . . as panic hits the rest of the world Hand sanitiser and respiratory...
...Jeff Henriksen is the co-founder and CEO of Thorpe Abbotts Capital, a value-oriented hedge fund based out of Charlottesville, Virginia, and Associate Fellow at the University of Oxford’s Saïd Business School...
...For Shirley White, her lungs impaired by chronic respiratory disease, it was a moment to savour: for the first time in years she could walk and talk at the same time....
...Warner Cable in 2016 $89bn Walt Disney in its planned acquisition of 21st Century Fox marquee assets (including debt) $30bn Chubb in its 2016 sale to ACE $29.4bn St Jude Medical in its 2016 sale to Abbott...
...Activist battles 2: Innoviva THE BUSINESS A respiratory drug company that receives royalties from GlaxoSmithKline for its asthma medications....
...(FT, Stat) Medical devices Medtronic followed Abbott and Johnson & Johnson in shrinking operations to focus on niche products. The company is selling its medical supplies business to Cardinal Health....
...Since last Thursday more than $55bn have been spent by large companies, including Abbott Laboratories, AbbVie and Sanofi to secure growth generating assets....
...Dr Lee previously worked at Abbott Laboratories, the US healthcare products group....
...Under the deal, which will give Alere an equity value of $5.8bn, Abbott will assume about $2.6bn of its debt. Abbott expected the acquisition to lift its total diagnostics sales to more than $7bn....
...Mylan this month struck a $5.3bn deal to buy a portfolio of generic drugs from Abbott Laboratories....
...As part of the deal, Mylan will secure more than 100 generic medicines for conditions that include gastroenteritis and respiratory problems that Abbott currently sells in developed markets outside the US...
....” ——————————————- The big picture for big pharma US Companies: Johnson & Johnson, Pfizer, Merck & Co, Gilead, Abbott, Eli Lilly, Amgen, AbbVie, Bristol-Myers Squibb Outlook: The fortunes of US big...
...Mr Subjally has been appointed head of global equities for RBC GAM and is joined by Neil Abbott, Luis Benoliel, Marcus Lun, Jeremy Richardson, Julie Thomas, Dag Wetterwald, Perry Winfield and Ben Yeoh as...
...If a majority of Elan’s voting shareholders approve the company’s planned debt issue and deals including the purchase of future royalties in US respiratory specialist Theravance, they will undermine Royalty...
...Pharmaceutical companies have become more actively involved in diagnostics in recent years, with some like Roche making acquisitions and others including Novartis and Abbott investing to expand their internal...
...It follows Elan’s planned $1bn payment to Theravance, a US-based biotech business, to acquire 21 per cent of the future royalties on four of its experimental respiratory medicines developed in partnership...
...“Over the past nine months, we have proven the power of an open platform, creating an ecosystem of literally hundreds of partners dedicated to making mobile commerce a reality,” said Michael Abbott, Isis...
...Respiratory drugs accounted for 40 per cent of GSK’s pharmaceuticals sales in 2012, so it is heavily invested in the success of these new treatments....
...Elan’s planned “poison pill” acquisitions – including the purchase of a share of royalties from Theravance , a specialist in respiratory medicines – were all defeated by investors....
International Edition